Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in California
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in California
| Provider | Medicare | Services |
|---|---|---|
| Chrome Residential, Llc | $139.78 | 22.0K |
| Path Md, Inc. | $139.78 | 21.6K |
| Skorokhod, Vladimir M.D. | $139.77 | 7.1K |
| Golden Star Labs Llc | $139.78 | 5.8K |
| Pathology Services Inc. | $139.78 | 4.3K |
| 911 Labs Inc | $139.78 | 3.3K |
| Spectrum Molecular Diagnostics... | $139.78 | 2.2K |
| Genentox Laboratories Llc | $139.78 | 1.8K |
| Gl Ca Clia Llc | $139.78 | 1.6K |
| Ohrelle Laboratories Inc | $139.78 | 1.4K |
| Usa Biosciences Llc | $139.78 | 1.1K |
| Valley Diagnostics Inc | $139.78 | 1.1K |
| Pasteur Inc | $139.78 | 1.0K |
| Prg Technologies, Inc | $139.78 | 963 |
| Illuminate Diagnostics Inc | $139.78 | 703 |
| Brio Clinical Inc | $139.78 | 406 |
| Igenex Inc | $139.78 | 347 |
| Sutter Valley Medical Foundation | $138.93 | 241 |
| Strategic Concepts Lab Llc | $136.04 | 231 |
| Pacific Medical Labs | $139.78 | 201 |
| Sher, Lawrence M.D. | $135.69 | 194 |
| Keller, Jon MD | $139.19 | 183 |
| First Bio Lab, Llc | $139.78 | 179 |
| Sutter Valley Medical Foundation | $139.78 | 125 |
| Sutter Valley Medical Foundation | $138.61 | 107 |
California Pricing in Context
In California, CPT code 87637 (Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus) carries an average Medicare payment of $139.73 — 0% above the national benchmark of $139.61. 662 providers across the state submitted claims for this procedure in 2023, performing 83.7K total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in California is $275.18, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in California lands near $335.35, with self-pay cash prices typically around $180.47. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cost in California?
The average Medicare payment for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in California is $139.73, which is 0% above the national average of $139.61. Providers in CA typically bill $275.18 for this procedure.
What does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cost with insurance in California?
With commercial insurance in California, Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus costs an estimated $335.35. Without insurance, the estimated cash price is $180.47. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in California?
662 providers in California billed Medicare for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in 2023, performing 83.7K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cheaper in California than the national average?
No — Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus costs 0% above the national average in California. The state average Medicare payment is $139.73 compared to $139.61 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.